Biotech Landscape and Outlook

## **MIT Club of Northern California & Harvard Club of Silicon Valley Present:**

**A Discussion with Silicon Valley’s Top Bio Movers and Shakers:**

**What Does the Future of Biotech Investing Look Like?**

Join us on May 23rd, 6:30 – 8:30 PM at 3150 Porter Drive, Palo Alto, CA for a captivating discussion on the future of Biotech Investing.

Our panelists include:

– Niki Santo, CEO, Swaza, Inc. (Panel Moderator)
– Elizabeth Ng, CEO, Ocean Biomedical (NASDAQ: OCEA)
– Keith Koo, Host of Silicon Valley Insider, Vice President, US Capital
– Eddie Eltoukhy, Ph.D., Partner at Pear VC | Life Sciences Venture Investing

Despite the biotechnology market’s promising future, some are calling the current period a “biotechnology winter,” with many companies trading for less than cash and reports of a slowdown in sector investment. The biotechnology market is expected to soar past $950B US by 2027, fueled by the need for solutions to chronic disease, the rapid development of bioengineering tools, and an intense interest in addressing diseases of aging. Our stellar panel, representing the top leaders in the biotech ecosystem, both investors and CEOs alike, will discuss what’s on the horizon, investment landscape perspectives, and emerging promising technologies. This will be followed by a networking reception for investors, startup founders and biotech enthusiasts. Confirmed in attendance are investors from top-tier firms and early to mid-stage biotech startup founders.

.PNG)